Log In
Print
BCIQ
Print
Print this Print this
 

Oleptro, trazodone (DDS-04A)

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionSerotonin antagonist reuptake inhibitor (SARI)
Molecular Target Serotonin (5-HT) receptor
Mechanism of ActionSerotonin (5-HT) reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat major depressive disorder (MDD); Treat major unipolar depressive disorder
Regulatory Designation

Partner

Gruppo Angelini


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$19.5M

$71.5M

$40.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today